Detalles de la búsqueda
1.
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.
Int J Clin Oncol;
2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38758397
2.
[Current Status and Issues of Companion Diagnostics for Non-Small Cell Lung Cancer].
Gan To Kagaku Ryoho;
51(4): 378-382, 2024 Apr.
Artículo
en Japonés
| MEDLINE | ID: mdl-38644300
3.
Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trial.
Lung Cancer;
191: 107557, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38626709
4.
KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non-small-cell lung cancer.
Invest New Drugs;
2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38530565
5.
Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer.
Invest New Drugs;
42(1): 136-144, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38300341
6.
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort.
Cancer Res Commun;
4(1): 226-235, 2024 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181055
7.
Brigatinib-related organizing pneumonia mimicking pulmonary infection.
Jpn J Clin Oncol;
54(3): 357-358, 2024 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38088031
8.
Five-Year Survival Outcomes After Carbon-Ion Radiotherapy for Operable Stage I NSCLC: A Japanese National Registry Study (J-CROS-LUNG).
J Thorac Oncol;
19(3): 491-499, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37924974
9.
Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer.
Heliyon;
9(10): e20463, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37822623
10.
Durvalumab Plus Concurrent Radiotherapy for Treatment of Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Phase 2 Nonrandomized Controlled Trial.
JAMA Oncol;
9(11): 1505-1513, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676681
11.
Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non-small-cell lung cancer in KEYNOTE-407.
Cancer Sci;
114(8): 3330-3341, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37183528
12.
Clinical results of proton beam radiotherapy for inoperable stage III non-small cell lung cancer: a Japanese national registry study.
J Radiat Res;
64(Supplement_1): i8-i15, 2023 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37137157
13.
Clinical results of carbon-ion radiotherapy for stage I non-small cell lung cancer with concomitant interstitial lung disease: a Japanese national registry study (J-CROS-LUNG).
J Radiat Res;
64(Supplement_1): i2-i7, 2023 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37036751
14.
Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: A Japanese national registry study (J-CROS-LUNG).
Radiother Oncol;
183: 109640, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36990390
15.
[Efficacy and Safety Analysis of Selpercatinib in Patients with RET Fusion-Positive Non-Small Cell Lung Cancer-Results from the Japanese Subset of a Global Phase 1/2 Study].
Gan To Kagaku Ryoho;
49(6): 669-675, 2022 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-35799394
16.
Psychological states regarding adjuvant chemotherapy in patients with non-small cell lung cancer.
Cancer Treat Res Commun;
32: 100591, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35749949
17.
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.
Int J Clin Oncol;
27(4): 695-706, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35182247
18.
Severe Skin Toxicity Caused by Sequential Anti-PD-1 Antibody and Alectinib in Non-small-cell Lung Cancer: A Report of Two Cases and a Literature Review.
Intern Med;
61(11): 1735-1738, 2022 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34803090
19.
Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinoma.
Front Oncol;
12: 966527, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36698400
20.
Rationale and Design for a Multicenter, Phase II Study of Durvalumab Plus Concurrent Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Study (WJOG11619L).
Cancer Manag Res;
13: 9167-9173, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34934361